Changes in body composition, and endocrine and metabolic functions in healthy elderly Chinese men following Growth Hormone therapy

Aging Male

Volumn 1, Issue 4, 1998, Pages 264-269

  Goh, V H H ^a   Mu, Shan Chu ^b   Gao, Fangkun ^c   Lim, Khye Sing ^d  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c BEIJING HOSPITAL   (China)

^d Ares Serono Singapore Private Limited   (Singapore)

Author keywords

Androgen; Body fat; Dehydroepiandrosterone sulfate; Growth hormone augmentation therapy; Insulin; Insulin growth factor I; Lean body mass; Thyroid hormones

Indexed keywords

EID: 25844509888     PISSN: 13685538     EISSN: None     Source Type: Journal    
DOI: 10.3109/13685539809148439     Document Type: Article

References (27)

1. Christiansen JS, Jorgensen JOC. Beneficial effects of GH replacement therapy in adults (mini review). Acta Endocrinol (Copenh) 1991;125:1-13
2. Bouillanne O, Rainfray M, Tissandier O, Nasr A, Lahlou A, Cnockaert X, et al. Growth hormone therapy in elderly people: an age-delaying drug? - A review. Foundam Clin Pharmacol 1996;10: 416-30
3. Benbassat CA, Maki KC, Unterman TG. Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures. J Clin Endocrinol Metab 1997; 82:1484-91
4. Gill MS, Toogood AA, O'Neill PA, Adams JE, Thorner MO, Shalet SM, et al. Relationship between growth hormone (GH) status, serum leptin and body composition in healthy and GH deficient elderly subjects. Clin Endocrinol 1997;47: 161-7
5. Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, et al. Effects of human growth hormone in men over 60 years old (see comments). N Engl J Med 1990;323:1-6
6. Rudman D, Feller AG, Cohn L, Shetty KR, Rudman IW, Draper MW. Effects of human growth hormone on body composition in elderly men. Horm Res 1991;36(Suppl 1):73-81
7. Cohn L, Feller AG, Draper MW, Rudman IW, Rudman D. Carpal tunnel syndrome and gynaecomastia during growth hormone treatment of elderly men with low circulating IGF-I concentrations. Clin Endocrinol Oxf 1993;39:417-25
8. Mu SC, Yu XJ, Qian ZQ, Zheng Q, Lim KS. A preliminary study of the effect growth hormone on body composition in elderly Chinese men. China J Geriatr 1997;16:27-9
9. Gao FY, Lui YS, Cheng JH, Dong M, Shong XL. The effect of short-term low dose growth hormone therapy on body composition in healthy elderly Chinese men. China J Geriatr 1997;17(Suppl):1-2
10. Sufi S, Donaldson A, Jeffcoate SL. Method Manual. WHO Special Programme of Research, Development and Research Training in Human Reproduction. Programme for the Provision of Matched Assay Reagents for the Radioimmunoassay of Hormones in Reproductive Physiology. Geneva: WHO, 1992
11. Chia SE, Goh VHH, Ong CN. Endocrine profiles of male workers with exposure to trichloroethylene. Am J Industr Med 1997;32:217-22
12. De Boer H, Blok GJ, Popp-Snijders C, Stuurman L, Baxter RC, van der Veen E. Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers. J Clin Endocrinol Metab 1996;81:1371-7
13. Snel YE, Doerga ME, Brummer RJ, Zelissen PM, Zonderland ML, Kooppeschaar HP. Resting metabolic rate, body composition and related hormonal parameters in growth hormone-deficient adults before and after growth hormone replacement therapy. Eur J Endocrinol 1995;133:455-50
14. De Boer H, Blok GJ, Voerman B, Derriks P, van der Veen E. Changes in subcutaneous and visceral fat mass during growth hormone replacement therapy in adult men. Int J Obes Relat Metab Disord 1996;20:580-7
15. Thoren M, Hilding A, Baxter RC, Degerblad M, Wivall-Heleryd IL, Hall K. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency. J Clin Endocrinol Metab 1997;82:223-8
16. Jorgensen JO, Moller J, Laursen T, Orskov H, Christiansen JS, Weeke J. Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults. Clin Endocrinol 1994;41: 609-14
17. Van Coevorden A, Mockel J, Laurent E, Kerkhofs M, L'Hermite-Baleriaux M, Decoster C, et al. Neuroendocrine rhythms and sleep in aging men. Am J Physiol 1991;260(4 Pt 1):E651-61
18. Scavina S, Sonka J, Haas T. Dehydroepiandrosterone and insulinaemia. Sb Lek 1995;96:303-6
19. Shealy CN. A review of dehydroepiandrosterone (DHEA). Integr Physiol Behav Sci 1995;30:308-13
20. Clore JN. Dehydroepiandrosterone and body fat. Obes Res 1995;Suppl 4:613S-16S
21. Daneberg HD, Haring R, Heldman E, Gurwitz D, Ben-Nathan D, Pittel Z, et al. Dehydroepiandrosterone augment M1-muscarinic receptor-stimulated amyloid percursor protein secretion in densensitized PC12M1 cells. Ann NY Acad Sci 1995;774:300-3
22. Friess E, Trachsel L, Guldner J, Schier T, Steiger A, Holsboer F. DHEA administration increases rapid eye movement sleep and EEG power in the sigma frequency range. Am J Physiol 1995;268: E107-13
23. Taniguchi S, Yanase T, Haji M, Ishibashi K, Takayanagi R, Nawata H. The antiobesity effect of dehydroepiandrostcrone in castrated or noncastrated obese Zucker male rats. Obes Res 1995; Suppl 5:639S-43S
24. Yen SSC, Morales AJ, Khorram O. Replacement of DHEA in aging men and women. Potential remedial effects. Ann NY Acad Sci 1995;774: 128-42
25. Berr C, Lafont S, Debuire B, Dartigues JF, Baulieu EE. Relationships of dehydroepiandrosterone sulfate in the elderly with function, psychological, and mental status, and short-term mortality: a French community-based study. Proc Natl Acad Sci USA 1996;93:13410-15
26. Vermeulen A. Juvenile hormones, reality or myth? A review. Verh K Acad Geneeskd Belg 1997;59: 19-33
27. Blok GJ, de Boer H, Gooren LJ, van der Veen EA. Growth hormone substitution in adult growth hormone-deficient men augments androgen effects on the skin. Clin Endocrinol 1997;47:29-36